|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/14/19 MediXall Group, Inc. 10-Q 9/30/19 41:1.8M Edgar Filing LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 301K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
33: R1 Document and Entity Information HTML 47K
14: R2 Condensed Consolidated Balance Sheets HTML 75K
23: R3 Condensed Consolidated Balance Sheets HTML 34K
(Parenthetical)
38: R4 Condensed Consolidated Statements of Operations HTML 50K
31: R5 Consolidated Statement of Changes in Stockholders' HTML 54K
Equity (Deficit)
13: R6 Consolidated Statement of Changes in Stockholders' HTML 17K
Equity (Deficit) (Parenthetical)
22: R7 Condensed Consolidated Statements of Cash Flows HTML 75K
37: R8 Organization and Nature of Operations HTML 18K
34: R9 Going Concern HTML 21K
17: R10 Summary of Significant Accounting Policies HTML 60K
25: R11 Related Party Transactions HTML 24K
36: R12 Preferred Stock HTML 16K
30: R13 Pending Legal Matters HTML 17K
16: R14 Lease HTML 36K
24: R15 Summary of Significant Accounting Policies HTML 104K
(Policies)
35: R16 Summary of Significant Accounting Policies HTML 47K
(Tables)
29: R17 Related Party Transactions (Tables) HTML 22K
15: R18 Lease (Tables) HTML 37K
26: R19 Going Concern (Details Narrative) HTML 24K
40: R20 Summary of Significant Accounting Policies HTML 20K
(Details)
28: R21 Summary of Significant Accounting Policies HTML 32K
(Schedule of Basic and Diluted LPS) (Details)
19: R22 Summary of Significant Accounting Policies HTML 22K
(Details Narrative)
21: R23 Related Party Transactions (Details) HTML 28K
39: R24 Related Party Transactions (Details Narrative) HTML 29K
27: R25 Preferred Stock (Details Narrative) HTML 18K
18: R26 Lease (Schedule of Components of Lease Expense and HTML 30K
Other Lease Information) (Details)
20: R27 Leases (Schedule of Future Minimum Lease HTML 26K
Commitments) (Details)
12: XML IDEA XML File -- Filing Summary XML 66K
41: EXCEL IDEA Workbook of Financial Reports XLSX 35K
6: EX-101.INS XBRL Instance -- mdxl-20190930 XML 515K
8: EX-101.CAL XBRL Calculations -- mdxl-20190930_cal XML 87K
9: EX-101.DEF XBRL Definitions -- mdxl-20190930_def XML 102K
10: EX-101.LAB XBRL Labels -- mdxl-20190930_lab XML 370K
11: EX-101.PRE XBRL Presentations -- mdxl-20190930_pre XML 276K
7: EX-101.SCH XBRL Schema -- mdxl-20190930 XSD 65K
32: ZIP XBRL Zipped Folder -- 0001553350-19-001178-xbrl Zip 53K
| Certification |
EXHIBIT 31.1
CERTIFICATIONS
I, Neil Swartz, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2019 of MediXall Group, Inc.; |
|
|
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 14, 2019
| /s/ Neil Swartz |
| |
| Interim Chief Executive Officer |
| (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/14/19 | None on these Dates | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||